Clinical Trials Logo

In Vitro Fertilization clinical trials

View clinical trials related to In Vitro Fertilization.

Filter by:

NCT ID: NCT02993588 Recruiting - Clinical trials for In Vitro Fertilization

Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate the impact of melatonin administration on in vitro fertilization (IVF/ICSI) outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders.

NCT ID: NCT02992665 Recruiting - Clinical trials for In Vitro Fertilization

Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine the impact of the use of calcium ionophore on the ICSI outcomes in couples with severe male factor infertility. Investigators conduct a randomized controlled trial on the sibling oocyte to justify the use of calcium ionophore in these cases.

NCT ID: NCT02477566 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI

Start date: December 2014
Phase: N/A
Study type: Interventional

To test whether long-acting Triptorelin on pituitary down-regulation can improve the clinical pregnancy rate and reduces the incidence of ovarian hyperstimulation syndrome (OHSS) in infertile high-risk patients with polycystic ovaries (PCOs) who underwent in vitro fertilization (IVF) or Intracytoplasmic sperm injection

NCT ID: NCT02215135 Recruiting - Clinical trials for In Vitro Fertilization

Corifollitropin Alfa Application in PCOS Patients

Start date: January 2014
Phase: Phase 4
Study type: Interventional

Corifollitropin alfa, single dose administered sustains multiple follicular development for 7 days. However, It may induce ovarian hyperstimulation syndrome (OHSS), especially in high responder women such as patients of polycystic ovary syndrome (PCOS). In GnRH antagonist protocol with agonist triggering of final oocyte maturation, following embryo cryopreservation can almost eliminate the risk of OHSS. To decrease the injection burden and prevent OHSS in PCOS patients undergoing IVF treatment, ovarian hyperstimulation with Corifollitropin alfa in GnRH antagonist protocol and GnRH agonist triggering of final oocyte maturation, following elective embryo cryopreservation was designed in this study. The purpose of this trial was conducted to confirmed whether this novel protocol could prevent OHSS, decreased the injection burden of PCOS patients and single dose corifollitropin alfa could support multiple follicular growth for 7 days.

NCT ID: NCT01507883 Recruiting - Clinical trials for In-vitro Fertilization

Time-lapse Evaluation of Human Embryo Development in Single Versus Sequential Culture Media - a Sibling Oocyte Study

Start date: March 2011
Phase: N/A
Study type: Observational

Current human IVF technology employs two strategies with respective culture media for embryo development; 'let the embryo choose' (utilizes single step media) and 'back-to-nature' (utilizes sequential media). To our knowledge, there is not any sibling oocyte study to evaluate potential advantages/disadvantages of these strategies on one another.

NCT ID: NCT01406600 Recruiting - Clinical trials for in Vitro Fertilization

Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI Cycles

Start date: September 2011
Phase: N/A
Study type: Interventional

Choriogonadotropin alfa (Ovidrel®) is a recombinant hCG (rhCG) preparation derived from genetically engineered Chinese hamster ovary cells, which is widely used for final oocyte maturation triggering in assisted reproductive technology (ART).Recombinant hCG has been investigated about its safety and efficacy comparing with urinary hCG, but still the optimal dose of rhCG is questionable. From former studies, there only have been proven that high dose of hCG can make ovarian hyperstimulation syndrome (OHSS) in usual condition. On the other hand, we hypothesize that high dose of hCG may improve oocyte maturity in poor responders who cannot easily provoke OHSS. Hence, this study will assess the comparative efficacy and safety of 250mcg and 500mcg of rhCG in ART treatment cycle.

NCT ID: NCT01347268 Recruiting - Clinical trials for In Vitro Fertilization

Comparing Coasting by Withholding GnRH Agonist With GnRH Antagonist

Start date: January 2011
Phase: Phase 4
Study type: Interventional

Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of ovulation induction and is a life threatening iatrogenic complication. In patients with GnRH agonist protocol, both withdrawing GnRH agonist and GnRH antagonist administration are associated with a reduction in (E2) levels with subsequent decreasing the incidence and severity of OHSS. This work is to compare the clinical and endocrine outcome response of cycles in which GnRH agonist withdrawing with cycles in which the GnRH antagonist administration in patients at risk of severe OHSS.

NCT ID: NCT01287273 Recruiting - Pregnancy Clinical Trials

The Impact of Early Embryos Incubation on Pregnancy Rate in IVF

IVF-2010
Start date: April 2011
Phase: N/A
Study type: Observational

Frozen- thawed embryos obtained by IVF treatments are transferred to the uterus immediately following thawing or after incubation for additional 24-72 hours. The two methods are routine in IVF laboratories. In this study the investigators would like to compare between these two methods in terms of implantation rate, pregnancy rate and delivery.

NCT ID: NCT01220791 Recruiting - Clinical trials for In Vitro Fertilization

Methylprednisolone Addition in IVF Treatment of Infertile Couples

Start date: January 2009
Phase: Phase 4
Study type: Interventional

Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently control late follicular progesterone rise during IVF treatment

NCT ID: NCT00826332 Recruiting - Clinical trials for In Vitro Fertilization

Transvaginal vs Transabdominal Ultrasound Guided Embryo Transfer

TVUSET
Start date: January 2009
Phase: Phase 1
Study type: Interventional

Embryo transfer is the last step in the IVF process. it is now recognized that this step should be done carefully and that it affects success rates. in recent years, sonographic guidance appears to increase success rates.